About
Autoimmune Treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
11
As Collaborator
0
Total Enrollment
4,356
By Phase
PHASE1: 4PHASE3: 3PHASE2: 4
By Status
ACTIVE_NOT_RECRUITING: 4RECRUITING: 3COMPLETED: 3TERMINATED: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06962774Lead Sponsor
An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function
PHASE1Recruiting
48 participants
Started: May 9, 2025 · Completed: Dec 31, 2025
NCT06952634Lead Sponsor
An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage
PHASE1Recruiting
48 participants
Started: Apr 29, 2025 · Completed: Dec 31, 2025
NCT06846541Lead Sponsor
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
PHASE3Recruiting
1,680 participants
Started: Jan 8, 2025 · Completed: Nov 30, 2028
NCT06588738Lead Sponsor
A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001
PHASE3Active, not recruiting
840 participants
Started: Aug 20, 2024 · Completed: Dec 31, 2025
NCT06586112Lead Sponsor
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis
PHASE3Active, not recruiting
840 participants
Started: Jul 25, 2024 · Completed: Dec 31, 2025
Locations (1)
Headquarters
South SF, CA, United States
Map
Loading map...